NEW YORK (GenomeWeb News) – A National Cancer Institute review panel has recommended that the Wistar Institute Cancer Center receive $14.9 million in renewal funding to support resources and infrastructure for a range of molecular cancer research activities.

The five-year renewal will fund Wistar's shared resources, which include molecular screening and imaging tools and genomics research technologies, Philadelphia-based Wistar said last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."